Which trial do we need? RSV booster vaccination in immunocompromised patients: Immunogenicity, safety and efficacy of booster vaccination strategies – Boost or bypass?

Clinical Microbiology and Infection · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles